Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

2019-03-07

British Journal of Haematology , Volume 186 - Issue 3 p. E7- E11

Additional Metadata
Keywords	decitabine, cytarabine, acute myeloid leukaemia, DNA methylation, ESR1, CDKN2B
Persistent URL	doi.org/10.1111/bjh.15847, hdl.handle.net/1765/119439
Journal	British Journal of Haematology
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kearns, P., Zwaan, M., Reinhardt, D., Gibson, B., Moreno, L., Nysom, K., … Nemat, S. (2019). Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia. British Journal of Haematology, 186(3), E7–E11. doi:10.1111/bjh.15847

Publication